Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Will the Dogs of the Dow Beat the Market?

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Following the "Dogs of the Dow" strategy is one of the simplest dividend methods for beating the market. Over the coming year, I'll track the Dogs' performance and keep you abreast of news affecting these companies.

The strategy
"Dogs of the Dow" refers to an investing strategy that buys and holds equal dollar amounts of the 10 best-yielding dividend stocks of the Dow Jones Industrial Average (INDEX: ^DJI  ) . The strategy banks on the idea that blue-chip stocks with high yields are near the bottom of their business cycle and should do much better going forward. Investors in the strategy then would get large not only dividends but also gains in the stocks underlying those dividends.

High-yield dividends
High-yield portfolios are often dismissed as inferior to their growth counterparts for various reasons:

  • Many people fear that increasing dividend yields mean lower portfolio returns.
  • Others believe that dividend payments mean management believes the business is done growing.

Evidence compiled by Tweedy Browne refutes these beliefs. Research shows that portfolios of high-yield dividend stocks outperform lower-yielding portfolios and the market in general. In fact, a study by noted finance professor Jeremy Siegel found that over 45 years, the highest-yielding 20% of S&P 500 stocks outperformed the S&P 500 by three times! The highest-yielding stocks turned a $1,000 investment in 1957 into $462,750 by 2002, compared with $130,768 if the same money was invested in the index.

The Dogs of the Dow returned 12.3% in 2011, which beat the Dow's return of 5.5%.

Check out the 2012 Dogs of the Dow performance so far:


Initial Yield

Initial Price

YTD Performance

AT&T 5.82% $30.24 (2.15%)
Verizon Communications 4.99% $40.12 (6.04%)
Merck (NYSE: MRK  ) 4.46% $37.70 2.18%
Pfizer (NYSE: PFE  ) 3.8% $21.64 (0.74%)
General 3.7% $17.91 6.25%
DuPont (NYSE: DD  ) 3.58% $45.78 10.79%
Johnson & Johnson 3.48% $65.58 (0.03%)
Intel 3.46% $24.25 10.23%
Procter & Gamble (NYSE: PG  ) 3.15% $66.71 (2.84%)
Kraft Foods 3.10% $37.36 2.97%
Dow Jones Industrial Average     3.63%
Dogs of the Dow     2.06%
Dogs Return vs. Dow (percentage points)     (1.56%)

Source: S&P Capital IQ as of Jan 27.

Since my last report, the Dow Jones Industrial Average fell 0.47%. The Dogs of the Dow fell more than the Dow, moving from outperforming the market by 1.6 percentage points to a 1.56-point disadvantage.

Movers and shakers
The biggest movers this week were Verizon and AT&T, which fell 4.51% and 4.41%, respectively. Both stocks reported disappointing earnings this week.

Earnings and news
Besides Verizon and AT&T, three other Dogs reported earnings this week.


  • Pfizer reports earnings on Tuesday. Analysts expect earnings per share of $0.47 and revenue of $16.61 billion.
  • Merck reports earnings on Thursday. Analysts expect earnings per share of $0.95 and revenue of $12.53 billion.

More dividends
Consider these 10 tickers along with the 11 names from a new free report from The Motley Fool's expert analysts called "11 Rock-Solid Dividend Stocks." Get instant access to the names of these 11 dividend stocks for free.

Dan Dzombak holds no position in any company mentioned. Check out his holdings and a short bio. The Motley Fool owns shares of Intel and Johnson & Johnson and has bought calls on Intel. Motley Fool newsletter services have recommended buying shares of Procter & Gamble, Pfizer, Intel, and Johnson & Johnson, creating a diagonal call position in Johnson & Johnson, and creating a bull call spread position in Intel. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (2) | Recommend This Article (8)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On January 29, 2012, at 12:09 PM, canadacomments wrote:


    Is the YTD Performance a stock price only number or a total return?

    I hadn't seen your previous posts on this topic but now will be following them. Good work!

  • Report this Comment On September 30, 2012, at 7:32 PM, melbil3436 wrote:

    same question as canadacomments. Glad I'm not the only one who wants to know.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1768092, ~/Articles/ArticleHandler.aspx, 10/25/2016 1:27:40 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 4 hours ago Sponsored by:
DOW 18,223.03 77.32 0.43%
S&P 500 2,151.33 10.17 0.47%
NASD 5,309.83 52.43 1.00%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/24/2016 4:56 PM
^DJI $18223.03 Up +77.32 +0.43%
DD $70.14 Up +0.44 +0.63%
DuPont CAPS Rating: ****
MRK $60.75 Down -0.45 -0.74%
Merck and Co. CAPS Rating: ****
PFE $32.13 Down -0.05 -0.16%
Pfizer CAPS Rating: ****
PG $84.10 Down -0.23 -0.27%
Procter and Gamble CAPS Rating: ****